Mycobacterium chelonae infection associated with adalimumab therapy

被引:16
作者
Diaz, F. [1 ]
Urkijo, J. C. [1 ]
Mendoza, F. [1 ]
de la Viuda, J. M. [1 ]
Blanco, M. [1 ]
Unzurrunzaga, A. [1 ]
Ayarza, R. [2 ]
机构
[1] Hosp Galdakao Usansolo, Dept Internal Med, Vizcaya 48960, Spain
[2] Hosp Galdakao Usansolo, Dept Microbiol, Vizcaya 48960, Spain
关键词
D O I
10.1080/03009740701716876
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:159 / 160
页数:2
相关论文
共 10 条
[1]   Anti-cytokine therapeutics and infections [J].
Dinarello, CA .
VACCINE, 2003, 21 :S24-S34
[2]   An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [J].
Griffith, David E. ;
Aksamit, Timothy ;
Brown-Elliott, Barbara A. ;
Catanzaro, Antonino ;
Daley, Charles ;
Gordin, Fred ;
Holland, Steven M. ;
Horsburgh, Robert ;
Huitt, Gwen ;
Iademarco, Michael F. ;
Iseman, Michael ;
Olivier, Kenneth ;
Ruoss, Stephen ;
von Reyn, C. Fordham ;
Wallace, Richard J., Jr. ;
Winthrop, Kevin .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (04) :367-416
[3]   Tumor necrosis factor is critical to control tuberculosis infection [J].
Jacobs, Muazzam ;
Togbe, Dieudonnee ;
Fremond, Cecile ;
Samarina, Arina ;
Allie, Nasiema ;
Botha, Tania ;
Carlos, Daniela ;
Parida, Shreemanta K. ;
Grivennikov, Sergei ;
Nedospasov, Sergei ;
Monteiro, Analbery ;
Le Bert, Marc ;
Quesniaux, Valerie ;
Ryffel, Bemhard .
MICROBES AND INFECTION, 2007, 9 (05) :623-628
[4]   Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy:: case report and review of infectious complications associated with tumor necrosis factor α inhibitor use [J].
Mufti, AH ;
Toye, BW ;
Mckendry, RRJ ;
Angel, JB .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (03) :233-238
[5]   Tumor-necrosis-factor blockers: Differential effects on mycobacterial immunity [J].
Saliu, Oluwabunmi Y. ;
Sofer, Carolina ;
Stein, Dana S. ;
Schwander, Stephan K. ;
Wallis, Robert S. .
JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (04) :486-492
[6]   Bacterial and opportunistic infections during anti-TNF therapy [J].
Strangfeld, Anja ;
Listing, Joachim .
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2006, 20 (06) :1181-1195
[7]  
VIRGINIAPEREZ M, 2005, CLIN EXP IMMUNOL, V141, P372
[8]   CLINICAL-TRIAL OF CLARITHROMYCIN FOR CUTANEOUS (DISSEMINATED) INFECTION DUE TO MYCOBACTERIUM-CHELONAE [J].
WALLACE, RJ ;
TANNER, D ;
BRENNAN, PJ ;
BROWN, BA .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (06) :482-486
[9]   SKIN, SOFT-TISSUE, AND BONE-INFECTIONS DUE TO MYCOBACTERIUM-CHELONAE-CHELONAE - IMPORTANCE OF PRIOR CORTICOSTEROID-THERAPY, FREQUENCY OF DISSEMINATED INFECTIONS, AND RESISTANCE TO ORAL ANTIMICROBIALS OTHER THAN CLARITHROMYCIN [J].
WALLACE, RJ ;
BROWN, BA ;
ONYI, GO .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :405-412
[10]  
YINT K, 2004, SCAND J INFECT DIS, V36, P150